UnitedHealth Group (UNH) Q1 2026 earnings summary

Executive summary

• Q1 2026 revenues reached $111.7 billion, up 2% year-over-year, with all major business segments exceeding plan and strong performance in Medicare and Optum Health.

• Adjusted EPS was $7.23 and GAAP EPS was $6.90, both ahead of expectations, supported by strong cash flows and reserves.

• Organization sharpened focus on U.S. healthcare, exited non-U.S. businesses, and refreshed nearly half of top leadership roles.

• Accelerated investments in AI, technology, and cybersecurity are improving productivity and reducing administrative burden.

• Community engagement and support initiatives expanded, especially in rural healthcare and behavioral health.

Financial highlights

• Total Q1 revenue was $111.7 billion, with premium revenue at $87.6 billion, products revenue at $13.3 billion, and services revenue at $9.8 billion.

• Medical care ratio improved to 83.9% from 84.8% in Q1 2025, reflecting pricing discipline and favorable reserve development.

• Operating cost ratio rose to 13.8% from 12.4% due to targeted investments in AI, technology, and restructuring.

• Operating income was $9.0 billion, with a net margin of 5.6% and operating margin of 8.0%.

• Operating cash flows were $8.9 billion, or 1.4x net income.

Outlook and guidance

• Full-year adjusted EPS outlook raised to greater than $18.25, with GAAP EPS expected to exceed $17.35.

• Expect approximately two-thirds of earnings in the first half of the year, with UnitedHealthcare and Optum Health earnings front-loaded.

• Optum Insight and Optum Rx earnings are expected to be back-half weighted, with AI investments driving future growth.

• Continued contraction in Medicare Advantage and Medicaid membership expected throughout 2026 due to funding pressures and eligibility reductions.

• Ongoing investments in technology, people, and process to drive future growth and efficiency.